Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2012; 18(18): 2161-2171
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2161
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2161
Study | Observed adverse event | Ascertainment | Results |
Bhatt et al[25] | Composite of upper gastrointestinal bleeding (of known and unknown origin): overt bleeding, ulcers, symptomatic erosions, obstruction, perforation or decrease in hemoglobin of 2 g/dL | Endoscopic and radiologic confirmation (in known origin subgroup) | Significative reduction of upper gastrointestinal bleeding in the omeprazole treated group (1.1% against 2.9% under placebo; HR 0.34, 95% CI: 0.18-0.63) |
Ray et al[27] | Hospitalization for bleeding at a gastroduodenal site (excluding angiodysplasia) or other gastrointestinal and non-gastrointestinal sites | Validated diagnostic codes with PPV of 91% | Adjusted 50% reduction of hospitalization in the PPI treated group (HR 0.50, 95% CI: 0.39-0.65), no significant difference concerning bleeding at other sites |
van Boxel et al[14] | Occurence of complicated or non complicated peptic ulcer disease | ICD-9 diagnostic codes | Low incidence (0.7% with PPI against 0.2%) but significant increase of peptic ulcer disease in the PPI treated group even after multivariable adjusting (HR 4.76, 95% CI: 1.18-19.17) |
Charlot et al[28] | Hospitalization for gastrointestinal bleeding | ICD-9 diagnostic codes | No reduction between the clopidogrel with PPI and clopidogrel alone group |
Harjai et al[29] | TIMI major bleeding: intracranial hemorrage or a ≥ 5 g/dL decrease in hemoglobine TIMI minor bleeding: observed blood loss with decrease ≥ 3 g/dL in hemoglobine | Guthrie Health System database | No significant difference between the clopidogrel with PPI and clopidogrel alone group |
Simon et al[30] | In-hospital major bleeding (not specified) or need for blood transfusion | FAST-MI registry | No significant difference between the clopidogrel with PPI and clopidogrel alone group |
- Citation: Drepper MD, Spahr L, Frossard JL. Clopidogrel and proton pump inhibitors - where do we stand in 2012? World J Gastroenterol 2012; 18(18): 2161-2171
- URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2161.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2161